COVID-19

Massimo Franchini1, Carlo Mengoli1, Arturo Casadevall2

  • 1Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, 46100 Mantua, Italy.

PubMed
概括

许多针对COVID-19康复性血 (CCP) 的随机对照试验 (RCT) 低估了样本大小,因为高效期望. 这导致了较低的统计能力,并可能影响试验结果,突出显示了关键治疗的样本大小估计的问题.